Audit-Ready Primer Design for Clinical Genomics and Diagnostics
Try VigyanLLM Free →VigyanLLM's clinical genomics platform provides automated validated clinical assay design with variant annotation for GLP-compliant research. Runs entirely on-premises via Docker deployment with no data egress.
Audit Trail for Every Design Decision
Clinical genomics requires documented validation for every primer and assay. VigyanLLM generates comprehensive audit-ready PDF reports that document: the target gene and transcript selected, every validation step result (Tm, GC content, specificity, secondary structure, SNP filtering, ClinVar annotation), the scoring rationale, and the final primer sequences with manufacturing specifications. This documentation supports GLP compliance and regulatory audit requirements.
Clinical Variant Integration
VigyanLLM integrates clinical variant databases to inform primer design decisions. When designing primers for clinical genotyping, the platform annotates target variants with ClinVar significance ratings (pathogenic, likely pathogenic, VUS, likely benign, benign), dbSNP allele frequencies, and population-specific data from gnomAD. This annotation helps clinical researchers select the most relevant targets and design assays with appropriate sensitivity for the variant allele frequency in their patient population.
Frequently Asked Questions: clinical genomics platform
Is VigyanLLM suitable for clinical genomics?
VigyanLLM is designed for clinical genomics workflows with several clinical-specific features: dbSNP-aware primer design (avoiding polymorphic binding sites), ClinVar variant annotation (pathogenicity classification), audit-ready PDF reports (every design decision documented), and on-premise deployment (data never leaves your infrastructure). While not a CE/IVD-marked diagnostic tool, it provides the validated design framework that clinical research labs need.
Part of VigyanLLM Genomics Research Hub — Explore all tools and resources for genomics research.